JP2014050390A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014050390A5 JP2014050390A5 JP2013209725A JP2013209725A JP2014050390A5 JP 2014050390 A5 JP2014050390 A5 JP 2014050390A5 JP 2013209725 A JP2013209725 A JP 2013209725A JP 2013209725 A JP2013209725 A JP 2013209725A JP 2014050390 A5 JP2014050390 A5 JP 2014050390A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- isolated peptide
- pharmaceutical composition
- residues
- pseudomonas aeruginosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 101900113211 Pseudomonas aeruginosa Azurin Proteins 0.000 claims 8
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 230000003902 lesion Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 210000001519 tissue Anatomy 0.000 claims 3
- 206010003571 Astrocytoma Diseases 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 2
- 201000010881 cervical cancer Diseases 0.000 claims 2
- 208000005017 glioblastoma Diseases 0.000 claims 2
- 201000010536 head and neck cancer Diseases 0.000 claims 2
- 208000014829 head and neck neoplasm Diseases 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 2
- 201000000849 skin cancer Diseases 0.000 claims 2
- 201000005112 urinary bladder cancer Diseases 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84435806P | 2006-09-14 | 2006-09-14 | |
| US60/844,358 | 2006-09-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009528468A Division JP2010503409A (ja) | 2006-09-14 | 2007-09-13 | クプレドキシンによって癌を予防する組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014050390A JP2014050390A (ja) | 2014-03-20 |
| JP2014050390A5 true JP2014050390A5 (https=) | 2014-05-01 |
Family
ID=39184582
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009528468A Withdrawn JP2010503409A (ja) | 2006-09-14 | 2007-09-13 | クプレドキシンによって癌を予防する組成物および方法 |
| JP2013209725A Pending JP2014050390A (ja) | 2006-09-14 | 2013-10-04 | クプレドキシンによって癌を予防する組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009528468A Withdrawn JP2010503409A (ja) | 2006-09-14 | 2007-09-13 | クプレドキシンによって癌を予防する組成物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2061498A4 (https=) |
| JP (2) | JP2010503409A (https=) |
| KR (1) | KR20090059152A (https=) |
| CN (1) | CN101595124A (https=) |
| AU (1) | AU2007296429A1 (https=) |
| BR (1) | BRPI0714987A2 (https=) |
| CA (1) | CA2663498A1 (https=) |
| IL (1) | IL197602A0 (https=) |
| MX (1) | MX2009002787A (https=) |
| NO (1) | NO20091267L (https=) |
| RU (1) | RU2009113812A (https=) |
| SG (1) | SG174784A1 (https=) |
| WO (1) | WO2008033987A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9096663B2 (en) | 2001-02-15 | 2015-08-04 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof |
| US7556810B2 (en) | 2005-07-19 | 2009-07-07 | The Board Of Trustees Of The University Of Ilinois | Compositions and methods to control angiogenesis with cupredoxins |
| US7381701B2 (en) | 2001-02-15 | 2008-06-03 | The Borad Of Trustees Of The University Of Illinois | Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
| US9434770B2 (en) | 2004-10-07 | 2016-09-06 | Tapas K Das Gupta | Modified cupredoxin derived peptides |
| US9598470B2 (en) | 2004-10-07 | 2017-03-21 | Craig W. Beattie | Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways |
| US9968685B2 (en) | 2004-10-07 | 2018-05-15 | Brad N. Taylor | Methods to treat cancer with cupredoxins |
| US10675326B2 (en) | 2004-10-07 | 2020-06-09 | The Board Of Trustees Of The University Of Illinois | Compositions comprising cupredoxins for treating cancer |
| UA97466C2 (ru) | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Транспортирующие соединения - производные купредоксина и способы их применения |
| AU2006269879A1 (en) | 2005-07-19 | 2007-01-25 | The Board Of Trustees Of The University Of Illinois | Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
| MX2009005849A (es) | 2006-12-04 | 2009-08-12 | Univ Illinois | Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas. |
| KR20090114414A (ko) | 2007-02-08 | 2009-11-03 | 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 | 쿠프레독신으로 암을 예방하는 조성물과 방법 |
| EP3688194A1 (en) * | 2017-09-29 | 2020-08-05 | Oncgnostics GmbH | Risk determination for neoplasia and cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7491394B2 (en) * | 2001-02-15 | 2009-02-17 | The Board Of Trustees Of The University Of Illinois | Cytotoxic factors for modulating cell death |
| CN1506375A (zh) * | 2002-12-12 | 2004-06-23 | 浙江养生堂天然药物研究所有限公司 | 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物 |
| UA97466C2 (ru) * | 2004-10-07 | 2012-02-27 | Ананда Чакрабарти | Транспортирующие соединения - производные купредоксина и способы их применения |
| EP1888106A4 (en) * | 2005-05-20 | 2009-01-14 | Univ Illinois | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH EPRININ SIGNALING USING CUPREDOXINS |
| MX2008000993A (es) * | 2005-07-19 | 2008-03-19 | Univ Illinois | Composiciones y metodos para controlar la angiogenesis con cupredoxinas. |
-
2007
- 2007-09-13 JP JP2009528468A patent/JP2010503409A/ja not_active Withdrawn
- 2007-09-13 AU AU2007296429A patent/AU2007296429A1/en not_active Abandoned
- 2007-09-13 EP EP07842403A patent/EP2061498A4/en not_active Withdrawn
- 2007-09-13 CN CNA2007800417624A patent/CN101595124A/zh active Pending
- 2007-09-13 CA CA002663498A patent/CA2663498A1/en not_active Abandoned
- 2007-09-13 BR BRPI0714987-5A patent/BRPI0714987A2/pt not_active Application Discontinuation
- 2007-09-13 RU RU2009113812/10A patent/RU2009113812A/ru unknown
- 2007-09-13 MX MX2009002787A patent/MX2009002787A/es not_active Application Discontinuation
- 2007-09-13 SG SG2011064334A patent/SG174784A1/en unknown
- 2007-09-13 WO PCT/US2007/078371 patent/WO2008033987A2/en not_active Ceased
- 2007-09-13 KR KR1020097007352A patent/KR20090059152A/ko not_active Withdrawn
-
2009
- 2009-03-15 IL IL197602A patent/IL197602A0/en unknown
- 2009-03-26 NO NO20091267A patent/NO20091267L/no not_active Application Discontinuation
-
2013
- 2013-10-04 JP JP2013209725A patent/JP2014050390A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014050390A5 (https=) | ||
| AU2018201997B2 (en) | Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions | |
| WO2015183963A3 (en) | Therapeutic compositions including redox-active parabenzoquinones and uses thereof | |
| EA201592250A1 (ru) | Пиразолопирролидиновые производные и их применение в лечение заболеваний | |
| WO2016004093A3 (en) | Therapeutic compositions including galectin-3 inhibitors and uses thereof | |
| BR112015009280A2 (pt) | preparações liofilizadas de melfalana flufenamida | |
| IL308807B2 (en) | Combination therapy for treating cancer | |
| CL2011000124A1 (es) | Compuestos derivados de 3-aril-4-heterociclil-pirazoles, inhibidores de proteina quinasa b-raf; metodo de inhibicion in vitro de la proteina quinasa b-raf; composicion farmaceutica; producto de combinacion farmaceutica; y su uso para el tratamiento del cancer. | |
| MX2017004592A (es) | Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos. | |
| EA201000365A1 (ru) | Гетероциклические амиды, пригодные для лечения злокачественного новообразования и псориаза | |
| MY199967A (en) | Combinations of lsd1 inhibitors for use in the treatment of solid tumors | |
| MD4539B1 (ro) | 4-Fenilpiridine substituite pentru tratamentul bolilor asociate cu receptorul NK-1 | |
| JP2012176978A5 (https=) | ||
| HRP20170531T1 (hr) | Novi terapijski pristupi za liječenje alzheimerove bolesti i povezanih poremećaja putem modulacije angiogeneze | |
| HK1204988A1 (en) | Methods and compositions for preventing or treating ophthalmic conditions | |
| NZ606480A (en) | Albumin binding peptide-mediated disease targeting | |
| EA201592254A1 (ru) | Производные пиразолопирролидин-4-она и их применение при лечении заболевания | |
| EA033054B1 (ru) | Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения | |
| PH12017500136A1 (en) | Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof | |
| UA107550C2 (uk) | Похідні естра-1,3,5(10),16-тетраєн-3-карбоксаміду, способи їх одержання, фармацевтичні препарати, що їх містять, та їх застосування для виготовлення лікарських засобів | |
| EA201171087A1 (ru) | СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ | |
| WO2015183995A3 (en) | Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof | |
| HRP20151165T1 (hr) | Inhibitori apoptoze i njihove uporabe | |
| CL2007003754A1 (es) | Compuestos derivados de aril(heteroaril)alquil-amina; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como bronquitis, enfisema pulmonar y epoc. | |
| ECSP13012847A (es) | Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparación. |